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It Is All About Value Now: The Data You Need to Collect
and How to Do It
AOA Critical Issues
Jay R. Lieberman, MD, Kevin J. Bozic, MD, MBA, William J. Mallon, MD, and Charles A. Goldfarb, MD

Abstract: Health care has entered an era where value and quality have become more important than just quantity. Patientreported outcomes are a critical aspect of the value equation. Orthopaedic surgeons will need to demonstrate that their
treatment regimens actually are enhancing their patients’ quality of life. In order to do this, the collection of prospective patientreported outcome data will be critical. For most patients, this will require the use of a general health survey and a disease-speciﬁc
questionnaire. Currently, most orthopaedic surgeons are not collecting this type of data. The questions are: What types of
patient-generated questionnaires can provide the information needed, and how can these data be collected in a cost-effective
manner? We will discuss what value means to payers and what the outcome measures are that are selected by various
orthopaedic subspecialty societies to evaluate patients who undergo total hip and knee arthroplasty as well as patients with
shoulder and knee problems, and we will review potential strategies to collect prospective patient-outcome data in a costeffective manner in the ofﬁce.

Currently, we are in an era where value and quality of care trump
quantity. Outcomes are a critical aspect of the value equation
because “value = outcomes/cost.” Orthopaedic surgeons will
need to demonstrate that their surgical procedures actually are
enhancing their patients’ quality of life. Therefore, the collection
of patient-reported outcome data is essential. By 2019, physicians
who do not track their outcomes will be subject to a 4% penalty
on the Centers for Medicare and Medicaid Services (CMS) payments1-3. Herein, we will review the outcome measures selected by
various specialty societies to evaluate patients who undergo total
hip and knee arthroplasty and patients with shoulder and knee

problems. In addition, we will review potential strategies to collect
data in a cost-efﬁcient manner in the ofﬁce.
What Does Value Mean to Payers?
Value in health care is deﬁned as patient-centered health outcomes per health care dollar spent to achieve those outcomes4.
Therefore, measuring outcomes is essential to improving value
in health care. However, given the paucity of information currently available on musculoskeletal outcomes, stakeholders
have used other methods to deﬁne and measure health-care
“quality” and “value.” For example, U.S. News and World Report
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and Consumer Reports have developed their own algorithms to
assign quality ratings to assess health-care provider performance. The domains used in these rating systems include
structural, process, and patient-experience measures. Structural measures, such as adoption of electronic health records
(EHRs), are easy to deﬁne and measure, but are not easily
modiﬁed by health-care providers5. Process measures, such as
administration of thromboembolism prophylaxis, are relatively
easy to measure and act upon. However, these measures may
not necessarily be correlated with outcomes that are important
to patients. Outcome data, such as infection rates and patientreported outcomes, are the most direct measure of quality.
However, measuring health outcomes is associated with its
own set of challenges: they can be costly to measure, there is
a time lag between the intervention and the outcome, and risk
adjustment is necessary when comparing outcomes across providers. Despite these limitations, there is increasing emphasis
on using patient-reported outcomes to measure value in health
care. Costs are the second part of the value equation, and accurate measurement of costs is crucial to understanding the true
value of delivered care. Costs, like outcomes, must be measured
at the patient level. The cost should include the total cost of all
resources used in treating a patient’s full cycle of care for a given
condition, including personnel, supplies, equipment, and space4.
While payers are using a variety of domains to assess quality
and value, they are increasingly focused on outcomes. Payers use
outcome data in value-based payment models and with beneﬁts
design to incentivize higher-value care. The CMS has implemented several value-based payment programs, including the
Bundled Payments for Care Improvement (BPCI), which incentivizes all providers involved in an episode of care to optimize
patient outcomes while reducing costs; the Hospital Value-Based
Purchasing Program, which provides incentive payments to
acute-care hospitals based on outcomes; and the Hospital Readmissions Reduction Program, which provides incentives to hospitals to reduce unnecessary hospital readmissions6-8. Commercial
payers, such as Cigna, are using beneﬁt design to encourage their
beneﬁciaries to seek care from providers with above-average outcomes. Cigna’s Centers of Excellence program identiﬁes hospitals
that demonstrate excellence in both patient outcomes and costefﬁciency for 18 inpatient surgical procedures and medical conditions9. Center of Excellence determinations are made publicly
available online for use in patient decision-making, and may be
factored into pay-for-performance agreements with some
hospitals in the Cigna network.
Among outcome measures, patient-reported outcome measures (PROMs), which include assessments of symptoms, function,
and quality of life reported directly by patients, increasingly are
being used in both clinical decision-making and value-based payment models. PROMs are especially important for assessing outcomes from treatments for which the primary goal is to reduce
pain and improve function and quality of life, and are thus increasingly recognized as the most relevant measure of value in orthopaedic surgery. CMS’s Comprehensive Care for Joint Replacement
(CJR) model, a mandatory bundled payment model for hip and
knee replacement, sets the stage for the use of PROMs in pay-
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ment10. Hospitals that voluntarily submit preoperative and postoperative general health and condition-speciﬁc PROMs data can
receive points toward their composite quality scores, which may
increase their ﬁnancial opportunity under the model11. The
PROMs data also will be used to ﬁnalize and test a hospital-level,
risk-adjusted PROMs performance measure for primary total hip
and knee arthroplasty, which may be used for value-based payment
in the future. Additionally, PROMs can inform the patientphysician shared decision-making process by comparing a patient’s
baseline pain and function to that of similar patients who are considering a given treatment option. PROMs also have been used to
predict whether patients will achieve clinically meaningful improvement in function and quality of life after total joint replacement11,12.
Total Hip and Knee Arthroplasty: Outcome Measure
Selection in the Bundled Payment Era
Original data collection strategies for patients who undergo total
hip and knee arthroplasty involved the surgeon’s assessment of a
patient’s overall pain and function. A variety of physiciangenerated forms have been used, including the Harris hip score,
the Knee Society Score, the Merle d’Aubigné score, and the University of California at Los Angeles (UCLA) Activity Score13-16.
Data collection in this manner is subject to surgeon detection
bias; with all of these measures, there is limited patient input.
PROMs allow patients to regularly report their outcome
without physician interpretation or bias. The patient can evaluate pain, function, and overall quality of life. The CJR model is
a mandatory bundled payment program that holds participant
hospitals ﬁnancially accountable for the cost and quality of the
90-day episode of care10. This is a 5-year program that commenced in April 2016. The CJR program incentivizes care coordination by evaluating the costs and the quality of care that are
associated with both inpatient and outpatient activities. There
will be winners and losers in the CJR model, and although
some hospitals will receive reconciliation payments from CJR
if certain cost and quality metrics are realized, other hospitals
will have to make reconciliation payments to CMS if the cost
and quality goals are not met. PROMs are being used to evaluate and monitor the quality of care. In years 4 and 5 of the
program, the use of PROMs reporting will be mandatory. Data
collection with respect to PROMs usually includes a general
health survey and a disease or condition-speciﬁc survey.
There are a number of different general health surveys
that can be used to assess a patient with hip or knee arthritis,
including the National Institutes of Health (NIH)-funded
Patient-Reported Outcomes Measurement Information System
(PROMIS); the Short Form-36 (SF-36) health survey; the Veterans
RAND 12-item (VR-12) health survey; and the EuroQol 5 dimensions (EQ-5D) measure17-19. There are also a number of different
patient-generated disease-speciﬁc surveys that can be used to
evaluate hip and knee patients, including the Western Ontario
and McMaster Universities Osteoarthritis Index (WOMAC),
the Oxford Hip and Knee Society Scoring System, the Hip Disability and Osteoarthritis Outcome Score (HOOS), and the Knee
Injury and Osteoarthritis Outcome Score (KOOS)20-24. Both the
HOOS and the KOOS include 42 items.
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As part of the CJR process, PROMs need to be collected both
preoperatively and postoperatively. The question is, what is the best
outcome measure to use for the collection of these data? The
HOOS and the KOOS were obvious potential choices. However,
surgeons were concerned that 42 items would be too much for
many patients to manage in an ofﬁce visit, and could hamper ﬂow
in the surgeon’s ofﬁce. There were also some concerns that some of
the questions in the HOOS and the KOOS were more appropriate
for patients with sports injuries rather than those undergoing total
hip or knee arthroplasty. Orthopaedic surgeons were searching for
a more user-friendly questionnaire that could provide the appropriate data. Therefore, Lyman et al. developed the KOOS, JR and
the HOOS, JR24,25. The KOOS, JR is a validated scoring system that
has 7 items for assessing stiffness, pain, and function. The HOOS,
JR is also a validated scoring system that has 6 items for assessing
pain and function. The advantages of these scoring systems are that
they are validated and user-friendly because there are a limited
number of questions. The weakness of both scoring systems is that
they do not assess rigorous activity, and more data may be needed
if patients are being evaluated for a research study. However, most
patients can ﬁll out these forms on digital tablets in <5 minutes.
The American Association of Hip and Knee Surgeons
(AAHKS) convened an outcomes summit in August 2015 that
included the American Association of Orthopaedic Surgeons
(AAOS), The Hip Society, The Knee Society, the American Joint
Replacement Registry (AJRR), the Yale Center for Outcomes
Research and Evaluation (CORE), the CMS, and various payers
to select potential outcome measures to be used for the CJR program. After this meeting, the orthopaedic organizations sent a joint
letter to the CMS recommending that either the VR-12 or the NIH
PROMIS be used as the general health survey and that the HOOS,
JR and the KOOS, JR be the disease-speciﬁc surveys for the PROMs
for the CJR program. These recommendations were accepted by
the CMS to use as the outcome measures for the CJR program.
As part of the CJR program, both cost and quality are being
assessed and are being used to determine eligibility for reconciliation payments to hospitals. Three aspects of quality are being
evaluated, including risk-stratiﬁed complication rates (RSCRs),
patient satisfaction scores (the Hospital Consumer Assessment of
Healthcare Providers and Systems [HCAHPS] survey), and the
prospective collection of PROMs. Hospitals must clear a quality
threshold to receive reconciliation payments. When assessing the
overall hospital quality level, there is a weighted formula where
the RSCR counts for 50%, the HCAHPS survey counts for 40%,
and the PROMs data count for 10%. The CJR model uses a
composite quality score (CQS) to link quality to payment to
the hospital. The CQS is determined by performance improvement on 2 quality measures. In addition, the submission of
PROMs by hospitals to the CMS can enhance the hospital’s overall ﬁnancial payments from the CJR program.

orders. Both quality-of-life and anatomic outcome instruments
were selected as primary measurement tools, and instruments for
disease states were chosen for research consideration. The following criteria were used to choose outcome instruments: (1)
PROMs; (2) ease of use for providers; (3) ease of use for patients;
(4) inexpensive or free and readily available to providers; and (5)
documented and known metrics, including reliability, validity,
and MCIDs (minimal clinically important differences).
Because the ASES overlaps by anatomic region with the
American Orthopaedic Society for Sports Medicine (AOSSM),
the Arthroscopy Association of North America (AANA), and
the American Society for Surgery of the Hand (ASSH), it was
important to meet with these groups to try to reach a consensus
so that the different groups would not be recommending different outcome instruments. Both the AOSSM and the AANA
formed committees to assess various outcome instruments. The 4
organizations had 3 meetings between July 2015 and March 2016.
The groups recommended the VR-1218 and the ASES
26
score to evaluate shoulder disorders. For research purposes,
the ASES recommended use of the WOSI (Western Ontario
Shoulder Instability Index)27, WOOS (Western Ontario Osteoarthritis of the Shoulder Index)28, and WORC (Western Ontario Rotator Cuff Index)29 instruments. For the elbow, the
ASES and the ASSH recommended the DASH (Disabilities of
the Arm, Shoulder and Hand) score30.
For sports knee problems, the AOSSM committee recommended use of the IKDC SKF (International Knee Documentation Committee Subjective Knee Form)31 and the Marx
Activity Scale32, while the AANA committee recommended
either the IKDC or the KOOS and the Marx Activity Scale.
Certainly, there are multiple outcome instruments that
can be used for shoulder, elbow, and knee injuries, and the various society committees recognized this. The use of the NIH
PROMIS was discussed at length because it uses computeradaptive technology (CAT), which allows hundreds of possible questions; the speciﬁc questions are tailored based on
earlier responses33. Although the PROMIS has been developed
by the NIH and may become a de facto standard, the committees of the various societies did not believe that, at this time,
there was sufﬁcient documentation of known metrics to recommend PROMIS for shoulder, elbow, and knee disorders.
The need to use different outcome instruments places
another burden of documentation on health-care providers.
Therefore, the instruments selected to measure outcomes will
have to become embedded within existing EHR systems or the
required documentation will become overly burdensome. Furthermore, in a recent article, Duncan et al. noted that the cost
of meeting various quality payment program standards is likely
greater than the potential penalties that will be imposed, so
surgeons may choose not to collect and track these data34.

What Outcomes Tools Should Be Used to Assess the
Shoulder, the Elbow, and the Knee?
In 2013, the American Shoulder and Elbow Surgeons (ASES)
established a value committee to determine which outcome
instruments should be used to evaluate shoulder and elbow dis-

Data Collection in the Ofﬁce in a Cost-Effective Way
The decision to collect PROMs involves the entire practice,
including the administration, the front-desk staff, the nursing
staff, and the physicians. The implementation of an effective
process for PROMs collection requires group agreement,
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capital (upfront and continuing), and ongoing staff time.
Before embarking on the process, the group must make difﬁcult decisions, including which PROMs to utilize, how the data
are to be utilized (research, patient care, or both), the timing of
data collection, and a PROMs collection strategy.
A few general strategy points are relevant for successful
implementation. First, useful PROMs data require, at a minimum, baseline (preintervention) and timely postintervention
data. If PROMs are used for patient care, data are collected at
each patient visit and potentially at regular intervals outside of
such visits (e.g., annual PROMs administration for patients with
total joint replacement). The mechanism of data collection is
irrelevant as long as questionnaires are completed in their entirety
and a high percentage of patients complete the questionnaire at
each time point. Finally, there must be seamless integration into
ofﬁce ﬂow without disrupting the overall patient experience or
the doctor-patient relationship. Appropriately utilized PROMs
data will complement and may even enhance the doctor-patient
relationship and increase patient satisfaction.
PROMs may be collected either electronically or via pen and
paper. However, traditional pen and paper is probably not costeffective. There is a cost associated with transferring the data to the
EHR, and missed questions, data-input errors, and lost questionnaires are practical limitations. Electronic completion includes inofﬁce completion via tablet or desktop computer, or completion
outside the ofﬁce via text, e-mail links, or a patient portal. The inofﬁce tablet completion option is increasingly popular given its
relatively low upfront cost and captive audience, which generates
high test completion. The format is familiar to patients, and the
process can be applied without slowing patient ﬂow in the clinic.
Furthermore, the tablet option may, depending on the PROMs
capability, utilize CAT to allow smart logic minimization of the
number of questions in order to shorten PROMs completion.
Completion via text or e-mail link is an effective option as well,
but compliance may be affected by patient familiarity with such
technology35. The patient portal is a part of the Merit-Based Incentive Payment System (MIPS), and its growing adoption provides
an increasingly relevant means for PROMs completion.
The implementation of PROMs has both upfront and continuing costs for the practice. These costs include hardware (tablet
computers) and software to establish the PROMs and manage the
link to the EHR, as well as data analysis. Personnel time is another
cost center that includes establishing the information ﬂow from
data capture to the EHR (primarily an upfront cost) as well as the
ongoing time required for management and day-to-day administration of the data collection. The ofﬁce staff will require training
to teach some patients how to use the tablet or a computer and, in
some cases, may need to help patients ﬁll out the forms. One
reason for physician-practice consolidation is the need for capital
for projects exactly like this in modern health care. Large groups
may internally establish and maintain a PROMs process that
ensures that institutionally owned data are readily accessible for
immediate patient care and research. There are a number of
commercial vendors providing turnkey operations that can effectively provide this service and allow easy comparison of data to
national benchmarks and data from other groups.
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Perhaps the most notable challenge in the implementation
is choosing a tool that is ideally suited to the practice type. PROMs
vary in purpose, including those designed to assess general health,
those for a particular anatomic region, and those designed for
particular diagnoses. Multispecialty practices face a greater challenge concerning physician agreement as to the ideal tool. Some
PROMs are ideally suited for data collection at every visit, especially those that utilize CAT to minimize time requirements,
making them ideal for patient-care use. Others may be better
suited for limited use (preintervention and at selected intervals
postintervention) because they are more time-consuming to
complete. As stated previously, the NIH PROMIS is a broadly
applicable system with numerous modules, some of which are
appropriate for orthopaedic surgery patients. PROMIS offers
CAT to speed test completion, and it has become increasingly
accepted for both research and clinical care by funding
agencies and journals alike. While performance assessment
of PROMIS continues, in general, it has performed well when
compared against historical, region-speciﬁc PROMs36-38.
As the U.S. health-care system continues its shift to a system that rewards value delivered to patients, measuring outcomes
(speciﬁcally patient-reported outcomes) is imperative. Integrating routine collection and use of PROMs into the clinical workﬂow is the ﬁrst step, and necessitates both health-informatics
expertise and a shift in culture to emphasize the relevance and
use of patient-reported outcomes in optimizing patient care.
Patients and providers must understand the value of using
PROMs to inform the shared decision-making process around
which treatment is best for a given patient. Finally, PROMs
will increasingly be used by payers and patients to hold providers accountable for outcomes, although additional
research is needed to understand how to appropriately incorporate PROMs into provider accountability programs. n
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